ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Insiders Sell Hard as APP Craters

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

ORTEX insider momentum data flags a wave of selling across large-cap US stocks over the past three months. AppLovin, Meta Platforms, Dell Technologies, The Charles Schwab Corporation, Datadog, and Quanta Services all score -100 on ORTEX's three-month insider momentum index. That is the lowest possible reading, meaning insiders have sold and not bought across the entire window.

AppLovin stands out most sharply. The stock has fallen 60% year-to-date, yet insider selling has not let up. The three-month momentum score sits at -100. Analysts still see 78% upside to their consensus target, but insiders are not backing that view with their own money.

Dell tells a different story. The stock is up 286% year-to-date, and insiders have used that rally to sell heavily. Both one-month and three-month momentum scores are pinned at -100. When insiders cash out into strength, it is worth noting.

Meta and Procter & Gamble also register -100 over three months. P&G is up 9% year-to-date. Meta has gained 6%.

On the buying side, European names dominate. GSK and AB Volvo lead the ORTEX insider momentum ranking for Europe over one month. Lennar and Corebridge Financial show the strongest recent buying signals among US names with market caps above $5bn.

Note: the ORTEX vendor insider database used here runs to September 8. More recent US Form 4 filings were unavailable in this environment.

Stocks in this article

How this article was generated

Generated
23 Oct 2026, 08:13
Prompt version
v1.0
Data sources
Institutional positioningAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.